The authors of a new commentary in the American Journal of Cardiology argued that well-balanced plant-based diets are good for the heart and good for society as a whole. 

The new-look device gained CE mark approval in Europe in 2020, but it has not been approved yet in the United States.

Researchers examined data from more than 900 patients, presenting their findings in the Journal of the American Heart Association.

Read our recap of some of the biggest FDA-related stories that impacted cardiology in the last month.

Nontraditional risk factors such as dementia, PTSD, bipolar disorder and low socioeconomic status are all important to consider when patients are candidates for aortic valve replacement. 

The companies were given 15 days to provide an adequate response to the FDA's warning. The agency said its next step could include legal action. 

The new analysis focused on data from more than 5,000 heart failure patients throughout Asia, the Middle East and Africa.

GE's board of directors has approved the spinoff of its healthcare business to a separate entity, GE HealthCare.

Several mainstream media outlets recently cast a bright spotlight upon the well-being of athletes who are returning to active rosters following injuries, causing many spectators to question the people in charge of making return-to-play decisions.